Its myxoid differentiation associated with a rearranged and apparently amplified allele of ALK fits with these genetic alterations seen in smooth muscle tumors in general [17] as well as in uterine myelofibroblastic tumors displaying myxoid features [18, 19] and may offer novel options for targeted therapy [20]. Here, ALK is linked to smooth muscle tumor.